PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

Some low points:

Nearly 1 billion OS count
No insider buying
PPS remains low (manipulation???)
Dilution (caused by compensation, compensating company execs, staff, and consortium)

Some high points:

No toxic financing, ever
Amazing progress with drug/device delivery platform
IND filing: http://ir.pharmacytebiotech.com/press-releases/detail/133/pharmacyte-biotech-moves-closer-to-filing-ind-with-naming
Pre-IND meeting with the FDA included: https://globenewswire.com/news-release/2017/02/13/916491/0/en/PharmaCyte-Biotech-Moves-Closer-to-Filing-IND-with-Naming-of-Comparator-Arm-for-Upcoming-Clinical-Trial-and-Discusses-Pivotal-Trial-Opportunity.html
Possible partnership in place (contingency???)
Janssen (Johnson&Johnson owned) attends multiple presentations (btw, Janssen recently dropped Capricor, and Janssen's Aduro fails trial)
Janssen's growing interest in drug/device delivery platform (Janssen has over 30 chemotherapy drugs and NEEDS a successful delivery platform)
NDA's were signed with big pharma: http://pharmacyte.com/pharmacyte-seeks-to-solve-pancreas-puzzle-with-cell-in-a-box/
PR regarding Johnson & Johnson: http://ir.pharmacytebiotech.com/press-releases/detail/82/johnson-johnson-and-big-pharma-could-find-a-diabetes
PharmaCyte then hired a former J & J exec: http://ir.pharmacytebiotech.com/press-releases/detail/94/pharmacyte-biotech-appoints-former-johnson-johnson
PharmaCyte CEO's recent meetings in Canada (Janssen presence/location).
Bavarian Nordic's recent expansion deal with Janssen: https://finance.yahoo.com/news/bavarian-expands-j-j-deal-084519162.html
Bavarian Nordic is the forerunner to Austrianova (PharmaCyte's owns 14.5% equity interest): http://ir.pharmacytebiotech.com/press-releases/detail/29/pharmacyte-biotechs-cancer-treatment-tumor
J & J has the largest presence in Canada of all pharmaceutical companies: https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/hn01768.html
Recently, PharmaCyte appointed Dr. Abecassis to their Board of Directors and Dr. Sher as their Chief Medical Officer:
http://pharmacyte.com/pharmacyte-biotech-appoints-dr-michael-m-abecassis-to-board-of-directors/
http://pharmacyte.com/pharmacyte-biotech-appoints-dr-linda-s-sher-as-chief-medical-officer/